Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT06031441 |
| Title | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Genentech, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Yale Cancer Center | RECRUITING | New Haven | Connecticut | 06520 | United States | Details |
| SCRI Oncology Partners | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
| St Vincent's Hospital Sydney | RECRUITING | Darlinghurst | New South Wales | 2010 | Australia | Details |
| Peter Maccallum Cancer Centre | RECRUITING | Melbourne | Victoria | 3000 | Australia | Details |
| Princess Margaret Cancer Centre | RECRUITING | Toronto | Ontario | M5G 1Z5 | Canada | Details |